These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8950407)

  • 41. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system.
    Lundstrom K; Turpin MP
    Biochem Biophys Res Commun; 1996 Aug; 225(3):1068-72. PubMed ID: 8780735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population.
    Staddon S; Arranz MJ; Mancama D; Perez-Nievas F; Arrizabalaga I; Anney R; Buckland P; Elkin A; Osborne S; Munro J; Mata I; Kerwin RW
    Schizophr Res; 2005 Feb; 73(1):49-54. PubMed ID: 15567076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia.
    Ebstein RP; Macciardi F; Heresco-Levi U; Serretti A; Blaine D; Verga M; Nebamov L; Gur E; Belmaker RH; Avnon M; Lerer B
    Hum Hered; 1997; 47(1):6-16. PubMed ID: 9017973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis.
    Jönsson EG; Flyckt L; Burgert E; Crocq MA; Forslund K; Mattila-Evenden M; Rylander G; Asberg M; Nimgaonkar VL; Edman G; Bjerkenstedt L; Wiesel FA; Sedvall GC
    Psychiatr Genet; 2003 Mar; 13(1):1-12. PubMed ID: 12605094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
    Spurlock G; Williams J; McGuffin P; Aschauer HN; Lenzinger E; Fuchs K; Sieghart WC; Meszaros K; Fathi N; Laurent C; Mallet J; Macciardi F; Pedrini S; Gill M; Hawi Z; Gibson S; Jazin EE; Yang HT; Adolfsson R; Pato CN; Dourado AM; Owen MJ
    Am J Med Genet; 1998 Feb; 81(1):24-8. PubMed ID: 9514583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of association of the dopamine D3 receptor gene polymorphism (BalI) in Chinese schizophrenic males.
    Saha N; Tsoi WF; Low PS; Basair J; Tay JS
    Psychiatr Genet; 1994; 4(4):201-4. PubMed ID: 7712115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report.
    Blum K; Braverman ER; Wood RC; Gill J; Li C; Chen TJ; Taub M; Montgomery AR; Sheridan PJ; Cull JG
    Pharmacogenetics; 1996 Aug; 6(4):297-305. PubMed ID: 8873216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia.
    Hänninen K; Katila H; Kampman O; Anttila S; Illi A; Rontu R; Mattila KM; Hietala J; Hurme M; Leinonen E; Lehtimäki T
    Neurosci Lett; 2006 Oct; 407(3):195-8. PubMed ID: 16973280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of dopamine D2 receptor molecular variant with schizophrenia.
    Arinami T; Itokawa M; Enguchi H; Tagaya H; Yano S; Shimizu H; Hamaguchi H; Toru M
    Lancet; 1994 Mar; 343(8899):703-4. PubMed ID: 7907680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome.
    Kahsar-Miller M; Boots LR; Azziz R
    Fertil Steril; 1999 Mar; 71(3):436-8. PubMed ID: 10065778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia.
    Kaiser R; Könneker M; Henneken M; Dettling M; Müller-Oerlinghausen B; Roots I; Brockmöller J
    Mol Psychiatry; 2000 Jul; 5(4):418-24. PubMed ID: 10889553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome.
    Mihara K; Kondo T; Suzuki A; Yasui-Furukori N; Ono S; Sano A; Koshiro K; Otani K; Kaneko S
    Am J Med Genet B Neuropsychiatr Genet; 2003 Feb; 117B(1):57-60. PubMed ID: 12555236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.
    Segman RH; Heresco-Levy U; Finkel B; Inbar R; Neeman T; Schlafman M; Dorevitch A; Yakir A; Lerner A; Goltser T; Shelevoy A; Lerer B
    Psychopharmacology (Berl); 2000 Nov; 152(4):408-13. PubMed ID: 11140333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between schizophrenia and DRD3 or HTR2 receptor gene variants.
    Baritaki S; Rizos E; Zafiropoulos A; Soufla G; Katsafouros K; Gourvas V; Spandidos DA
    Eur J Hum Genet; 2004 Jul; 12(7):535-41. PubMed ID: 15083167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation and association analysis of the 5' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia.
    Ishiguro H; Okuyama Y; Toru M; Arinami T
    Mol Psychiatry; 2000 Jul; 5(4):433-8. PubMed ID: 10889555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia.
    Li T; Arranz M; Aitchison KJ; Bryant C; Liu X; Kerwin RW; Murray R; Sham P; Collier DA
    Schizophr Res; 1998 Jul; 32(2):87-92. PubMed ID: 9713903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies.
    Li XN; Zheng JL; Wei XH; Wang BJ; Yao J
    BMC Med Genet; 2020 Apr; 21(1):85. PubMed ID: 32316934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population.
    Xiao L; Shen T; Peng DH; Shu C; Jiang KD; Wang GH
    J Int Med Res; 2013 Aug; 41(4):1171-8. PubMed ID: 23816932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No association between the DRD3 Ser9Gly polymorphism and schizophrenia.
    Fathalli F; Rouleau GA; Xiong L; Tabbane K; Benkelfat C; Deguzman R; Zoltan D; Lal S; D'cruz S; Joober R
    Schizophr Res; 2008 Jan; 98(1-3):98-104. PubMed ID: 17698325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia.
    Lung FW; Tzeng DS; Shu BC
    Schizophr Res; 2002 Oct; 57(2-3):239-45. PubMed ID: 12223255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.